Redhill Biopharma Ltd.

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also rose, gaining, 0.19% to 4,877.88. Check This Out: How To Earn $500 A Month From Capital One Financial Ahead Of Its Q4 Earnings Report   Leading and Lagging Sectors   Energy shares rose by 1.7% on Thursday. In trading on Thursday, consumer discretionary shares fell by 1.5%.   Top Headline   American Airlines Group Inc (NASDAQ: AAL) reported better-than-expected fourth-quarter results. American Airlines reported a 75% drop in adjusted earnings to 29 cents per share in the fourth quarter of 2023 but still came in well above the consensus estimate of 10 cents per share. Total revenue decreased 1% to $13.06 billion, just beating estimates of $13.02 billion. American Airlines expects its full-year 2024 adjusted earnings per diluted share of $2.25-$3.25 versus the consensus of $2.25.   Equities Trading UP   Vera Therapeutics, Inc. (NASDAQ: VERA) shares shot up 53% to $25.97 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Shares of Processa ...

Related tickers: AMSC, COLB, HZO, VERA, RDHL, AAL, PCSA.

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...

Related tickers: RDHL, MRAI, MPX, AAL, IMMX, NOK, NEP, ALTI, CCTG, ORI, RR, AMSC, CISS, POL, VIRT, COLB, VSME, TAL, CNXC, EPIX, URI, EVA, RVSN, WRB, AKTS, ALK, XRX, INSG, ATI, TSLA, CMND, CRS, VERA, PCSA, CYN, ALPN, HUT, HUM, PHUN, RXT, HXL, PROP, ONCO, AFIB, HZO, CRGE, LVTX, IBM, ADT, BMEA, LPL.